Bipolar Disorder Treatment Market Marks Significant Growth at 5.2% CAGR by Top 10 Global Leaders as Takeda Pharmaceutical Company Limited, Pfizer, Inc., Allergan plc

Market Overview:

Bipolar disorder is a serious mental disorder characterized by extreme swings in mood occurring without any known cause or catalyst. Bipolar disorder is divided into two main subtypes, namely, Bipolar I disorder (BP-I) and Bipolar II disorder (BP-II). Symptoms may include an extremely high or low mood commonly known as hypomania. They can also involve episodes of clinical depression, rapid cycling bipolar disorder, and seasonal affective disorder. Bipolar disorder is sometimes referred to as manic depressive or bipolar disorder.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2605

Competitive Landscape:

Major players operating in the global bipolar disorders treatment market include, AbbVie Inc., AstraZeneca Plc, Allergan plc, Eli Lilly and Company, Gedeon Richter Plc, GlaxoSmithKline plc, H. Sumitomo Dainippon Pharma Co., Ltd., Indivior PLC., Intra-Cellular Therapies Inc., Johnson & Johnson, Lundbeck A/S, Minerva Neurosciences, Novartis International AG, Otsuka Holdings Co. Ltd., Pfizer, Inc., and Takeda Pharmaceutical Company Limited.

Key Market Drivers:

R&D of new therapies is expected to propel growth of the global bipolar disorders treatment market over the forecast period. For instance, in January 2021, BetterLife Pharma Inc. applied for patent protection of new 2-Bromo-LSD formulations and their use in the treatment of depression and mood disorders.

Similarly, in July 2020, BioXcel Therapeutics, Inc. announced that BXCL501, a proprietary sublingual thin film of dexmedetomidine, met the primary and secondary endpoints in studies aiming the treatment of schizophrenia and bipolar disorder.

Covid-19 Impact Analysis

Emergence of Covid-19 has increased the cases of neurological diseases around the world. According to a study published in September 2020, in JAMA Network Open, COVID-19 has tripled the rate of depression in US adults in all demographic groups—especially in those with financial worries. Such scenario is expected to aid in growth of the global bipolar disorders treatment market.

Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/2605

Key Takeaways

Major players operating in the global bipolar disorders treatment market are focused on approval and launch of new products to expand their product portfolio. For instance, in October 2020, OWP Pharmaceuticals, Inc. received approval for its Investigational New Drug application from the U.S. Food and Drug Administration for the first-ever liquid formulation of quetiapine fumarate for the treatment of schizophrenia and bipolar disorder.

Reasons to Purchase this Report

• Current and future of global Bipolar Disorder Treatment Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations

Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/2605

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Drug Class
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Key Developments
   • PEST Analysis
4. Global Bipolar Disorder Treatment Market, By Drug Class, 2016 – 2027, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Antipsychotics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Antidepressants
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Mood Stabilizers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Anti-anxiety Drugs and Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
5. Global Bipolar Disorder Treatment Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
6. Global Bipolar Disorder Treatment Market, By Region, 2016 – 2027, (US$ Mn)
   • Introduction
     • Market Share Analysis, By Region, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, For Regions, 2017–2027
   • North America
     • Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • U.S.
       • Canada
   • Latin America
     • Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • Germany
       • U.K.
       • France
       • Italy
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
       • South Africa
       • Central Africa
       • North Africa